Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    December 2017
  1. RADKOWSKI M, Opoka-Kegler J, Cortes KC, Bukowska-Osko I, et al
    Corrigendum: Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.
    J Gen Virol. 2017;98:3122.
    PubMed     Text format    


    November 2017
  2. GOONAWARDANE N, Ross-Thriepland D, Harris M
    Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000975.
    PubMed     Text format     Abstract available


    October 2017
  3. KELLY L, Badhan A, Roberts GC, Mbisa JL, et al
    Manipulation of both virus- and cell-specific factors is required for robust transient replication of a hepatitis C virus genotype 3a sub-genomic replicon.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000932.
    PubMed     Text format     Abstract available


    August 2017
  4. YANG CH, Li HC, Ku TS, Wu PC, et al
    Hepatitis C virus down-regulates SERPINE1/PAI-1 expression to facilitate its replication.
    J Gen Virol. 2017 Aug 31. doi: 10.1099/jgv.0.000901.
    PubMed     Text format     Abstract available


    July 2017
  5. FENG Y, Feng YM, Lu C, Han Y, et al
    Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo.
    J Gen Virol. 2017 Jul 31. doi: 10.1099/jgv.0.000869.
    PubMed     Text format     Abstract available


  6. MANUYLOV VA, Chub EV, Kichatova VS, Soboleva NV, et al
    Hepatitis C virus subtype 3a was introduced in the USSR in the early 1980s.
    J Gen Virol. 2017 Jul 26. doi: 10.1099/jgv.0.000878.
    PubMed     Text format     Abstract available


  7. GRIGOROV B, Molle J, Rubinstein E, Zoulim F, et al
    CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000850.
    PubMed     Text format     Abstract available


  8. KASSELA K, Karakasiliotis I, Charpantidis S, Koskinas J, et al
    High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
    J Gen Virol. 2017 Jul 15. doi: 10.1099/jgv.0.000851.
    PubMed     Text format     Abstract available


  9. CAMPOS GRF, Bittar C, Jardim ACG, Shimizu JF, et al
    Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    J Gen Virol. 2017 Jul 12. doi: 10.1099/jgv.0.000808.
    PubMed     Text format     Abstract available


  10. YI Z, Yuan Z
    Aggregation of a hepatitis C virus replicase module induced by ablation of p97/VCP.
    J Gen Virol. 2017 Jul 10. doi: 10.1099/jgv.0.000828.
    PubMed     Text format     Abstract available


    June 2017
  11. HULLEGIE SJ, Arends JEA, Groothuismink ZMA, Pas SD, et al
    Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
    J Gen Virol. 2017 Jun 8. doi: 10.1099/jgv.0.000768.
    PubMed     Text format     Abstract available


    May 2017
  12. RAJ M, Langley M, McArthur SJ, Jean F, et al
    Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells.
    J Gen Virol. 2017 May 26. doi: 10.1099/jgv.0.000754.
    PubMed     Text format     Abstract available


    February 2017
  13. DAS S, Mullick R, Kumar A, Tandon H, et al
    Identification of a novel epitope in the C-terminus of HCV-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    J Gen Virol. 2017 Feb 3. doi: 10.1099/jgv.0.000735.
    PubMed     Text format     Abstract available


  14. NAIK AS, Palmer BA, Crosbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody-associated hepatitis C virus.
    J Gen Virol. 2017;98:179-189.
    PubMed     Text format     Abstract available


    January 2017
  15. UCHIDA T, Imamura M, Kan H, Hiraga N, et al
    Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    J Gen Virol. 2017 Jan 28. doi: 10.1099/jgv.0.000726.
    PubMed     Text format     Abstract available


  16. VENTURA M, Martin L, Jaubert C, Andreola ML, et al
    HCV intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence.
    J Gen Virol. 2017 Jan 27. doi: 10.1099/jgv.0.000719.
    PubMed     Text format     Abstract available


    December 2016
  17. NIEDER-ROHRMANN A, Dunnes N, Gerresheim GK, Shalamova LA, et al
    Cooperative enhancement of translation by two adjacent microRNA-122/Argonaute 2 complexes binding to the 5 untranslated region of Hepatitis C Virus RNA.
    J Gen Virol. 2016 Dec 23. doi: 10.1099/jgv.0.000697.
    PubMed     Text format     Abstract available


  18. FLETCHER N, Clark AR, Balfe P, McKeating J, et al
    TNF superfamily members promote hepatitis C virus entry via an NF-kappaB and myosin light chain kinase dependent pathway.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000689.
    PubMed     Text format     Abstract available


    November 2016
  19. NAIK AS, Palmer BA, Crossbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody associated Hepatitis C Virus.
    J Gen Virol. 2016 Nov 14. doi: 10.1099/jgv.0.000659.
    PubMed     Text format     Abstract available


  20. KWAK J, Tiwari I, Jang KL
    Hepatitis C virus Core activates proteasomal activator 28 gamma expression via upregulation of p53 levels to control virus propagation.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000655.
    PubMed     Text format     Abstract available


  21. ZHANG H, Zhang J, Chen L, Weng Z, et al
    Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000656.
    PubMed     Text format     Abstract available


  22. SMITH DB, Becher P, Bukh J, Gould EA, et al
    Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.
    J Gen Virol. 2016;97:2894-2907.
    PubMed     Text format     Abstract available


    October 2016
  23. JIAO XY, Steenbergen RH, Tyrrell DL
    The use of human umbilical cord blood serum is beneficial for the continuous production of hepatitis C virus.
    J Gen Virol. 2016 Oct 24. doi: 10.1099/jgv.0.000636.
    PubMed     Text format     Abstract available


    September 2016
  24. WASILEWSKI L, Ray S, Bailey JR
    Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication competent virus and pseudoparticles.
    J Gen Virol. 2016 Sep 21. doi: 10.1099/jgv.0.000608.
    PubMed     Text format     Abstract available


  25. DU X, Pan T, Xu J, Zhang Y, et al
    Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5.
    J Gen Virol. 2016 Sep 16. doi: 10.1099/jgv.0.000607.
    PubMed     Text format     Abstract available


    August 2016
  26. VERSTREPEN B, Nieuwenhuis IG, Mooij P, Verschoor EJ, et al
    Role for microbial translocation in soluble CD14 up-regulation in HIV, but not in HCV, infected chimpanzees.
    J Gen Virol. 2016 Aug 16. doi: 10.1099/jgv.0.000577.
    PubMed     Text format     Abstract available


  27. MANSOOR S, Riaz S, Kausar S, Muhammad Din S, et al
    Can IFNL3 polymorphisms predict response to interferon/ribavirin treatment in hepatitis C patients with genotype 3?
    J Gen Virol. 2016 Aug 5. doi: 10.1099/jgv.0.000572.
    PubMed     Text format     Abstract available


    July 2016
  28. GATHER T, Walter S, Todt D, Pfaender S, et al
    Vertical transmission of hepatitis C virus-like nonprimate hepacivirus in horses.
    J Gen Virol. 2016 Jul 26. doi: 10.1099/jgv.0.000561.
    PubMed     Text format     Abstract available


  29. CHAN SW
    Hydrogen peroxide induces La cytoplasmic shuttling and increases hepatitis C virus internal ribosome entry site-dependent translation.
    J Gen Virol. 2016 Jul 18. doi: 10.1099/jgv.0.000556.
    PubMed     Text format     Abstract available


  30. URBANOWICZ RA, McClure CP, King B, Mason CP, et al
    Novel functional hepatitis C virus glycoprotein isolates identified using an optimised viral pseudotype entry assay.
    J Gen Virol. 2016 Jul 6. doi: 10.1099/jgv.0.000537.
    PubMed     Text format     Abstract available


    June 2016
  31. MCCLURE CP, Urbanowicz RA, King BJ, Cano-Crespo S, et al
    Flexible and rapid construction of viral chimeras applied to Hepatitis C Virus.
    J Gen Virol. 2016 Jun 21. doi: 10.1099/jgv.0.000530.
    PubMed     Text format     Abstract available


  32. FAN W, Xie S, Zhao X, Li N, et al
    IFN-lambda4 desensitizes the response to IFN-alpha treatment in chronic hepatitis C through long-term induction of USP18.
    J Gen Virol. 2016 Jun 14. doi: 10.1099/jgv.0.000522.
    PubMed     Text format     Abstract available


    May 2016
  33. AWAN Z, Tay ES, Eyre NS, Wu LE, et al
    Calsyntenin-1 mediates hepatitis C virus replication.
    J Gen Virol. 2016 May 24. doi: 10.1099/jgv.0.000511.
    PubMed     Text format     Abstract available


  34. EARNEST-SILVEIRA L, Chua B, Chin R, Christiansen D, et al
    Characterisation of a hepatitis C virus like particle vaccine produced in a human hepatocyte-derived cell line.
    J Gen Virol. 2016 May 4. doi: 10.1099/jgv.0.000493.
    PubMed     Text format     Abstract available


    March 2016
  35. NAIK AS, Palmer BA, Crosbie O, Kenny-Walsh E, et al
    A single amino acid change in the hypervariable region 1 of HCV genotype 4a aids humoral immune escape.
    J Gen Virol. 2016 Mar 4. doi: 10.1099/jgv.0.000447.
    PubMed     Text format     Abstract available


  36. LI YP, Van Pham L, Uzcategui N, Bukh J, et al
    Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against specific antagomir.
    J Gen Virol. 2016 Mar 2. doi: 10.1099/jgv.0.000445.
    PubMed     Text format     Abstract available


    February 2016
  37. QIAN XJ, Jin YS, Chen HS, Xu QQ, et al
    Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.
    J Gen Virol. 2016 Feb 15. doi: 10.1099/jgv.0.000432.
    PubMed     Text format     Abstract available


  38. SUZUKI R, Saito K, Matsuda M, Sato M, et al
    Single-domain Intrabodies against HCV Core Inhibit Viral Propagation and Core-induced NF-kappaB Activation.
    J Gen Virol. 2016 Feb 9. doi: 10.1099/jgv.0.000423.
    PubMed     Text format     Abstract available


    January 2016
  39. MOHL BP, Bartlett C, Mankouri J, Harris M, et al
    Early events in the generation of autophagosomes are required for the formation of membrane structures involved in hepatitis C virus genome replication.
    J Gen Virol. 2016 Jan 4. doi: 10.1099/jgv.0.000387.
    PubMed     Text format     Abstract available


    November 2015
  40. REN Y, Wang W, Zhang X, Xu Y, et al
    Evidence for Deleterious Hepatitis C Virus Quasispecies Mutation Loads that Differentiate the Response Patterns in Interferon-based Antiviral Therapy.
    J Gen Virol. 2015 Nov 18. doi: 10.1099/jgv.0.000346.
    PubMed     Text format     Abstract available


    October 2015
  41. COTTAREL J, Plissonnier ML, Kullolli M, Pitteri S, et al
    FIG4 is a Hepatitis C Virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential.
    J Gen Virol. 2015 Oct 29. doi: 10.1099/jgv.0.000331.
    PubMed     Text format     Abstract available


  42. PACIELLO R, Urbanowicz RA, Riccio G, Sasso E, et al
    Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb.
    J Gen Virol. 2015 Oct 29. doi: 10.1099/jgv.0.000330.
    PubMed     Text format     Abstract available


    September 2015
  43. PEREZ-DEL-PULGAR S, Gregori J, Rodriguez-Frias F, Gonzalez P, et al
    Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors.
    J Gen Virol. 2015 Sep 21. doi: 10.1099/jgv.0.000289.
    PubMed     Text format     Abstract available


  44. DOMINGUES P, Bamford CG, Boutell C, McLauchlan J, et al
    Inhibition of Hepatitis C Virus RNA Replication by ISG15 does not Require Its Conjugation to Protein Substrates by the HERC5 E3 Ligase.
    J Gen Virol. 2015 Sep 10. doi: 10.1099/jgv.0.000283.
    PubMed     Text format     Abstract available


    July 2015
  45. DENG L, Chen M, Tanaka M, Ku Y, et al
    HCV upregulates Bim through the ROS/JNK signaling pathway, leading to Bax-mediated apoptosis.
    J Gen Virol. 2015 Jul 3. doi: 10.1099/jgv.0.000221.
    PubMed     Text format     Abstract available


  46. KORBA B, Shetty K, Medvedev A, Viswanathan P, et al
    Hepatitis C Virus Genotype 1a Core Gene Nucleotide Patterns Associated with Hepatocellular Carcinoma Risk.
    J Gen Virol. 2015 Jul 3. doi: 10.1099/jgv.0.000219.
    PubMed     Text format     Abstract available


    June 2015
  47. PFAENDER S, Walter S, Todt D, Behrendt P, et al
    Assessment of cross-species transmission of hepatitis C-related non-primate hepacivirus in a population of humans at high risk of exposure.
    J Gen Virol. 2015 Jun 3. pii: vir.0.000208. doi: 10.1099/vir.0.000208.
    PubMed     Text format     Abstract available


    May 2015
  48. MATSUI C, Sianipar IR, Minami N, Deng L, et al
    A single-amino-acid mutation in hepatitis C virus NS5A disrupts physical and functional interaction with the transcription factor HNF-1alpha.
    J Gen Virol. 2015 May 8. pii: vir.0.000179. doi: 10.1099/vir.0.000179.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: